Expert in pharmaceutical due diligence, Mathieu Nocent implements collaboration management and CMC evaluation strategies for external opportunities. His experience in assessing and selecting new chemical and biological entities makes him a valuable asset for supporting companies in mergers, acquisitions, and partnerships. He also has strong expertise in industrial transfer analysis and regulatory risk assessment.

• Due Diligence
• CMC Evaluation
• Industry Partnerships
• Regulatory Risks
• External Opportunities